These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 12811549)

  • 21. Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.
    von Marschall Z; Scholz A; Cramer T; Schäfer G; Schirner M; Oberg K; Wiedenmann B; Höcker M; Rosewicz S
    J Natl Cancer Inst; 2003 Mar; 95(6):437-48. PubMed ID: 12644537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor.
    Zhou J; Tang ZY; Fan J; Wu ZQ; Ji Y; Xiao YS; Shi YH; Li XM; Sun QM; Liu YK; Ye SL
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6030-7. PubMed ID: 14676129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential.
    Tang ZY; Sun FX; Tian J; Ye SL; Liu YK; Liu KD; Xue Q; Chen J; Xia JL; Qin LX; Sun SL; Wang L; Zhou J; Li Y; Ma ZC; Zhou XD; Wu ZQ; Lin ZY; Yang BH
    World J Gastroenterol; 2001 Oct; 7(5):597-601. PubMed ID: 11819839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibition of angiogenesis of LCI-D20 hepatocellular carcinoma by metronomic chemotherapy of S-1].
    Chen FG; Wang JJ; Xue Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):665-8. PubMed ID: 19785953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A decade's studies on metastasis of hepatocellular carcinoma.
    Tang ZY; Ye SL; Liu YK; Qin LX; Sun HC; Ye QH; Wang L; Zhou J; Qiu SJ; Li Y; Ji XN; Liu H; Xia JL; Wu ZQ; Fan J; Ma ZC; Zhou XD; Lin ZY; Liu KD
    J Cancer Res Clin Oncol; 2004 Apr; 130(4):187-96. PubMed ID: 14685850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.
    Wang Z; Zhou J; Fan J; Tan CJ; Qiu SJ; Yu Y; Huang XW; Tang ZY
    J Cancer Res Clin Oncol; 2009 May; 135(5):715-22. PubMed ID: 19002496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
    Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
    Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
    Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
    Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST
    Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibition of human gastric cancer metastasis by ocreotide in vitro and in vivo].
    Wang C; Tang C
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):19-22. PubMed ID: 11953120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
    Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice.
    Wang L; Wu WZ; Sun HC; Wu XF; Qin LX; Liu YK; Liu KD; Tang ZY
    J Gastrointest Surg; 2003; 7(5):587-94. PubMed ID: 12850669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti‑angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
    Min L; Ling W; Hua R; Qi H; Chen S; Wang H; Tang L; Shangguan W
    Mol Med Rep; 2016 Mar; 13(3):2518-26. PubMed ID: 26846752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.
    Sun XT; Yuan XW; Zhu HT; Deng ZM; Yu DC; Zhou X; Ding YT
    World J Gastroenterol; 2012 Sep; 18(35):4925-33. PubMed ID: 23002366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
    Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.